Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 31 AL 45

Statins and cognitive function: an updated review

Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, Ro R, Agarwal V, Sardar P, Danik J, Giri JS, DeGoma EM, Kumbhani DJ.

Curr Cardiol Rep. 2015 Feb;17(2):4. doi: 10.1007/s11886-014-0559-3.

Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection

Kaur U, Banerjee P, Bir A, Sinha M, Biswas A, Chakrabarti S.

Curr Top Med Chem. 2015;15(5):446-57. doi: 10.2174/1568026615666150114160543.

The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease

Gomes B, Loureiro JA, Coelho MA, Pereira Mdo C.

Curr Pharm Des. 2015;21(39):5725-35. doi: 10.2174/1381612821666150130120358.

Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect

Miguel-Álvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, Lucia A.

Drugs Aging. 2015 Feb;32(2):139-47. doi: 10.1007/s40266-015-0239-z.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850.

The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease

Wright JW, Harding JW.

J Alzheimers Dis. 2015;45(4):985-1000. doi: 10.3233/JAD-142814.

Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis

Srinivasan M, Lahiri DK.

Expert Opin Ther Targets. 2015 Apr;19(4):471-87. doi: 10.1517/14728222.2014.989834. Epub 2015 Feb 4.

Contractures in end-stage Alzheimer's disease may respond to low-dose corticosteroid treatment: report of three cases

Winegarden JA, Carr DB, Bradshaw Y.

J Palliat Med. 2015 Mar;18(3):208-9. doi: 10.1089/jpm.2014.0399. Epub 2015 Feb 6.

The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy

Morgen K, Frölich L.

J Neural Transm (Vienna). 2015 Apr;122(4):499-504. doi: 10.1007/s00702-015-1377-5. Epub 2015 Feb 12.

Retinoic acid as a therapeutic option in Alzheimer's disease: a focus on cholinergic restoration

Szutowicz A, Bielarczyk H, Jankowska-Kulawy A, Ronowska A, Pawełczyk T.

Expert Rev Neurother. 2015 Mar;15(3):239-49. doi: 10.1586/14737175.2015.1008456. Epub 2015 Feb 15.

APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective

Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, Van Eldik LJ, LaDu MJ.

J Neurochem. 2015 May;133(4):465-88. doi: 10.1111/jnc.13072. Epub 2015 Mar 18.

Nanotherapeutic strategies for the treatment of Alzheimer's disease

Gu X, Chen H, Gao X.

Ther Deliv. 2015 Feb;6(2):177-95. doi: 10.4155/tde.14.97.

Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors

Dadashpour S, Tuylu Kucukkilinc T, Unsal Tan O, Ozadali K, Irannejad H, Emami S.

Arch Pharm (Weinheim). 2015 Mar;348(3):179-87. doi: 10.1002/ardp.201400400. Epub 2015 Feb 18.

Drosophila models of Alzheimer's disease: advances, limits, and perspectives

Bouleau S, Tricoire H.

J Alzheimers Dis. 2015;45(4):1015-38. doi: 10.3233/JAD-142802.

Building a roadmap for developing combination therapies for Alzheimer's disease

Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C.

Expert Rev Neurother. 2015 Mar;15(3):327-33. doi: 10.1586/14737175.2015.996551.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias